Harnessing Multilateral Financing for Health Security Preparedness
April 3, 2019
The economic consequences of large-scale disease outbreaks can be enormous: pandemics could cause $570 billion per year in average economic losses over the coming decades. Health security threats have an especially destructive impact on development investments and GDP in low-income and lower-middle-income countries (LICs and LMICs): the 2014-2015 Ebola outbreak in West Africa wiped out nearly five years of existing investments in the region, gravely setting back the region’s future development prospects. By contrast, upgrading countries’ preparedness is relatively inexpensive and affordable; recent data demonstrates most countries would need to spend approximately $0.50-$1.50 per person per year to get an acceptable level of epidemic preparedness.
The financing gap for preparedness is one of the starkest problems in health security, especially among LICs and LMICs. That gap is estimated at $4.5 billion per year. Investments in preparedness are cost-effective and affordable, but low-income and lower-middle-income country governments continue to underinvest at dangerously low levels. These governments bear lead responsibility for addressing financing gaps, but external funding can be catalytic. At present, there is no financing mechanism and no adequate incentive structure to motivate governments in high-risk countries to invest in preparedness, particularly when those investments compete with more visible priorities such as education, housing, transport infrastructure, and other pressing health needs. As a consequence, countries remain ill-prepared and vulnerable to the persistent threat of pandemics and large-scale disease outbreaks.
The World Bank Group’s International Development Association (IDA) replenishment takes place every three years and presents a choice opportunity to make adjustments that reflect important emerging priorities. In the current IDA19 replenishment, stakeholders can take a major step towards closing the preparedness financing gap by incentivizing $1 billion or more per year in preparedness investments in LICs and LMICs.
Pandemics and high-risk disease outbreaks spread quickly, rapidly infect large numbers of people, and can escalate swiftly into regional epidemics or even a global pandemic. Estimates are that an influenza pandemic could infect billions, kill millions, and damage the global economy.1 The risk of health security threats is especially high in fragile and conflict-affected settings, concentrated among low-income countries (LICs). The ongoing, highly-dangerous Ebola outbreak in the Democratic Republic of the Congo is the second-largest Ebola outbreak in history and presents a significant, escalating threat to the region and potentially beyond. Responders struggle amid continued violent attacks, community resistance, weak existing health security capacity, and insufficient international financing.
Underinvesting in preparedness undermines other critically important health objectives. For example, outbreak threats endanger ongoing efforts to combat antimicrobial resistance (AMR). AMR can contribute to serious illness and death during a large-scale outbreak and is a major health security risk globally in its own right. The AMR threat is rising, as common infections become deadly due to widespread drug resistance.
Investments in preparedness are central to achieving universal health coverage. Health systems only become effective at protecting and improving health when they achieve core public health functions of preparedness and response, such as antimicrobial stewardship, disease surveillance, laboratory networks, community health workers, healthcare infection control, and emergency operations centers. The absence of preparedness in LICs and lower-middle-income countries (LMICs) creates dangerous vulnerabilities outside the borders of these countries. Preparedness by individual national governments is essential to creating shared and reliable protection from unforeseen, sudden health security threats.
Investing in preparedness yields significant returns. The potential economic impact of large-scale outbreaks is huge: pandemics could cause average annual economic losses of 0.7 percent of global GDP, or $570 billion each year, over the coming decades.2 On the other hand, the cost of preparedness for the next health security crisis is relatively modest, with an estimated cost of $4.5 billion per year.3
Source: Yamey, Gavin et al., “Financing of international collective action for epidemic and pandemic preparedness,” The Lancet Global Health, 2017 https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(17)30203-6/fulltext.
Without strong preparedness systems already in place, outbreaks are much more likely to spread out of control and undermine development investments. For example, the 2014-2015 Ebola outbreak in West Africa caused at minimum $2.8 billion in losses in GDP in the three most affected countries, primarily through disruptions in mineral and agricultural production, trade, new investment, banking, and transport.4,5 The outbreak wiped out nearly five years of World Bank Group (WBG) investments in the region and set back the region’s future development prospects.
Since 2014, 45 IDA-eligible countries have undertaken a national preparedness assessment (a Joint External Evaluation, or JEE)6 of their capacity to prevent, detect, and respond to epidemics and pandemics. Of these countries, 31 have already developed National Health Security Action Plans to address these gaps. None of these action plans has been adequately financed.
National Preparedness Assessment (JEE) Scores, IDA countries only
Source: See Prevent Epidemics athttps://preventepidemics.org/.
The costs of upgrading defenses against health security threats are just a fraction of the resulting costs of epidemics. Recent costings suggest that most countries would need to spend $0.50-$1.50 per person per year to get to an acceptable level of epidemic preparedness.7 For most countries, this is less than 2 percent of what is spent on healthcare.
Strengthening health security preparedness often receives very low priority in country budgets, despite the catastrophic risk to health and economies from a major epidemic. Many low-income countries underinvest in preparedness due to a lack of resources. A related factor is that preparedness creates outcomes that are often not visible, competing against investments in roads, housing, and education.
Why Do LICs and LMICs Underinvest in Preparedness?
There is a need to create new financial mechanisms that incentivize low-income countries to increase investments in their preparedness and begin to close the $4.5 billion global funding gap. Low-income and lower-middle-income country investments in basic preparedness are strikingly low. Bilateral development assistance for health security will continue to play an important role in closing the financing gap, but dedicated funding for increasing preparedness in low-income countries has been limited. The United States led the way in this area through the $1 billion in Ebola supplemental funding appropriated by Congress for fiscal years 2015-2019, and these investments should be sustained post-2019 as part of the U.S. commitment to the Global Health Security Agenda. The G7, South Korea, and Australia have also pledged resources, but the size and sustainability of these funding streams fall far short of what is required. For the United States and other donors, the challenge is to find a combination of regularly budgeted bilateral investments and multilateral investments to adequately finance preparedness investments in low-income countries.
On the multilateral front, over the past several years the World Bank Group has established itself as the leading international financier for health emergency preparedness and response in LICs and LMICs. It can do more. The WBG’s International Development Association (IDA), its fund for the poorest countries, has a Crisis Response Window (CRW) that provided grant funds for the Ebola emergency response efforts in 2014.8 IDA is also supporting some discrete country preparedness efforts such as the Regional Disease Surveillance Systems Enhancement Program (REDISSE) in West Africa. However, although IDA’s shareholders made enhancing preparedness a special focus of the IDA18 replenishment in 2016, to date this has not yielded sufficient resources devoted to preparedness. One conclusion: new catalytic financial mechanisms are needed.
The IDA19 Replenishment is a choice opportunity to achieve at least $1 billion per year in new investments in preparedness by LICs and LMICs. In addition to continuing the progress made through increasing allocations with existing World Bank mechanisms and projects, the pathways that might achieve this objective, singly or in combination, are threefold:
- Expand the remit of IDA’s existing Crisis Response Window : The CRW, with a current allocation of $3 billion over three years, is designed to provide countries with additional financing that is over and above their regular IDA allocations so they can respond to economic crises, natural disasters, and public health emergencies without encroaching on existing development investments. The CRW provided funds for the Ebola emergency response efforts starting in 2014. Its mandate and allocation could be expanded to create the IDA Crisis Preparedness and Response Window, equipped with an additional $1 billion per year to LICs and LMICs for preparedness, on top of the CRW’s current allocation. This expansion is consistent with the CRW’s aim to improve countries’ resilience to future crises. Results-based financing could also be linked to the CRW.
- Link additional domestic financing for preparedness to results: The WBG has experience using a variety of IDA tools that could be used to catalyze increased investments in preparedness. For example, the WBG can promote “buy downs” that convert IDA loans to grants if countries achieve agreed performance benchmarks. Using this vehicle, the WBG could augment countries’ IDA domestic budget allocations for preparedness with additional grant financing after countries demonstrate improvements in core prevention, detection, and emergency response capabilities.
- Establish a new global financing mechanism dedicated to health security preparedness : Modeled on the Global Financing Facility for Every Woman and Every Child, donors could establish a new global financing platform with a primary aim to align and mobilize additional resources in support of country preparedness plans, including domestic budget resources, IDA, and other international public and private-sector financing. Donors willing to fund a new mechanism have not been identified.
Whichever pathway(s) is chosen, the goal is to achieve at least an additional $1 billion per year into preparedness investments in LICs and LMICs. The financing gap for preparedness is an enduring and dangerous problem in health security. There is a strong political and investment case for leveraging IDA to address the gap in low-income countries, and the IDA19 replenishment presents a key opportunity to take action. Concrete options are available, and with sufficient political will, World Bank shareholders and IDA deputies have the ability to begin to achieve significant progress in narrowing the financing gap in creating sustainable preparedness capacities.
For complete bios, please visit https://healthsecurity.csis.org/members.
Kelly Ayotte served in the U.S. Senate from 2011-2017 and previously served as New Hampshire’s first female attorney general from 2004-2009.
Congressman Ami Bera (D-CA) serves on the House Committee on Foreign Affairs and is the vice chair of the House Committee on Science, Space, and Technology.
Congresswoman Susan Brooks (R-IN) serves on the House Energy and Commerce Committee where she focuses on mental health, substance abuse, biodefense and telecommunications issues.
Beth Cameron is the vice president for Global Biological Policy and Programs at the Nuclear Threat Initiative (NTI) and previously helped develop and launch the Global Health Security Agenda.
Steve Davis is president and CEO of PATH and was previously director of Social Innovation at McKinsey & Company.
Mark Dybul is the faculty director of the Center for Global Health and Quality at the Georgetown University Medical Center and previously served as head of both the Global Fund to Fight AIDS, Tuberculosis and Malaria, and PEPFAR.
Tom Frieden is president and CEO of Resolve to Save Lives and previously served as director of the U.S. CDC from 2009 to 2017.
Julie Gerberding is executive vice president and chief patient officer at Merck and previously served as director of the U.S. CDC from 2002 to 2009.
Amanda Glassman is chief operating officer and a senior fellow at the Center for Global Development and previously served as a principal technical lead at the Inter-American Development Bank for 14 years.
Admiral Jonathan Greenert is the John M. Shalikashvili Chair in National Security Studies at the National Bureau of Asian Research (NBR) and previously served as the 30th chief of naval operations from 2011 to 2015.
Jim Greenwood is president and CEO of the Biotechnology Innovation Organization (BIO) and previously represented Pennsylvania's Eighth District in the U.S. House of Representatives from 1993 to 2005.
General Carter Ham is the president and CEO of the Association of the United States Army and previously served as commander of the United States Africa Command.
Margaret “Peggy” Hamburg is the foreign secretary of the National Academy of Medicine (NAM) and previously served as commissioner of the U.S. Food and Drug Administration (FDA) from 2009 to 2015
Karl Hofmann is the president and CEO of Population Services International (PSI) and was previously a career American diplomat for 23 years.
Tom Inglesby is the director of the Center for Health Security of the Johns Hopkins Bloomberg School of Public Health.
Rebecca Katz is an associate professor and director of the Center for Global Health Science and Security at Georgetown University.
Jimmy Kolker is a non-resident senior associate with the CSIS Global Health Policy Center and retired in January 2017 as assistant secretary for global affairs at the U.S. Department of Health and Human Services (HHS).
J. Stephen Morrison is senior vice president at CSIS and is director of its Global Health Policy Center, and previously served in the Clinton administration, as committee staff in the U.S. House of Representatives.
Carolyn Reynolds is a non-resident senior associate with the CSIS Global Health Policy Center and was previously vice president for policy and advocacy at PATH.
Christine Wormuth is the director of the International Security and Defense Policy Center at RAND Corporation and was previously under-secretary of defense for policy (USDP) at the U.S. Department of Defense.
Senator Todd Young (R-IN) serves on the Senate Committees on Foreign Relations; Finance; Commerce, Science, and Transportation; and Small Business and Entrepreneurship.
Juan Zarate is a senior adviser at the Center for Strategic and International Studies (CSIS), chairman and co-founder of the Financial Integrity Network, and a visiting lecturer in law at the Harvard Law School.
The authors benefited enormously from the assistance provided by Emily Foecke Munden, associate fellow with the CSIS Global Health Policy Center, and Madison Hayes, research consultant with the CSIS Global Health Policy Center.
This brief is a product of the CSIS Commission on Strengthening America’s Health Security, generously supported by the Bill & Melinda Gates Foundation.
CSIS Briefs are produced by the Center for Strategic and International Studies (CSIS), a private, tax-exempt institution focusing on international public policy issues. Its research is nonpartisan and nonproprietary. CSIS does not take specific policy positions. Accordingly, all views, positions, and conclusions expressed in this publication should be understood to be solely those of the author(s).
© 2019 by the Center for Strategic and International Studies. All rights reserved.
1Bill Gates, “Innovation for Pandemics,” New England Journal of Medicine 378, no. 22 (May 2018): 2057-2060, DOI: 10.1056/NEJMp1806283.
2Victoria Fan, Dean Jamison, and Lawrence Summers, “The Inclusive Cost of Pandemic Influenza Risk,” National Bureau of Economic Research Working Paper No. 22137, March 2016, https://www.nber.org/papers/w22137.
3Commission on a Global Health Risk Framework for the Future, “The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises,” National Academy of Medicine, 2016, https://www.nap.edu/catalog/21891/the-neglected-dimension-of-global-security-a-framework-to-counter.
4World Bank Group, “2014-2015 West Africa Ebola Crisis: Impact Update,” 2016, http://pubdocs.worldbank.org/en/297531463677588074/Ebola-Economic-Impact-and-Lessons-Paper-short-version.pdf.
5The total global economic and social costs of the 2014-2015 Ebola outbreak are now estimated to be $53.19 billion. See Caroline Huber, Lyn Finelli, and Warren Stevens, “The Economic and Social Burden of the 2014 Ebola Outbreak in West Africa,” The Journal of Infectious Diseases 218, (October 2018): p.S698–S704, https://academic.oup.com/jid/article/218/suppl_5/S698/5129071.
6The Joint External Evaluation (JEE) is a transparent, external evaluation of a country’s ability to find, stop, and prevent disease threats. It assesses capacities across 19 areas of epidemic preparedness and response that are scored first by a group of domestic experts and then by an external group of international experts. The assessment is voluntary and conducted every five years. The results are reported by the World Health Organization. For more information visit: https://extranet.who.int/sph/ihrmef.
7See: International Working Group on Financing Preparedness (IWG), From Panic and Neglect to Investing in Health Security: Financing Pandemic Preparedness at a National Level (Washington, DC: World Bank, December 2017),http://documents.worldbank.org/curated/en/979591495652724770/pdf/115271-REVISED-FINAL-IWG-Report-3-5-18.pdf. The IWG estimates $0.50-$1 per person per year would be needed, although there is variation in cost estimates by country. The range of $0.50-$1.50 captures most reasonable estimates.
8The World Bank’s International Development Association (IDA), created in 1960, provides grants and low- to zero-interest loans to developing countries using the backing of multilateral donors. IDA is overseen by the 173 shareholder countries which comprise the Board of Governors. IDA is funded largely by contributions from the governments of richer countries. A smaller amount of contributions come from the income of the International Bank for Reconstruction and Development (IBRD) and International Finance Corporation (IFC) and from borrowers’ repayments of earlier IDA credits. Every three years, partners meet to replenish IDA funds and review its policies. The United States is the largest contributor historically (22 percent), with Japan, Germany, the United Kingdom, and France rounding out the top five. Due to its large contribution to the most recent replenishment, the United Kingdom is now the second largest contributor. The most recent replenishment of IDA’s resources, IDA18, was finalized in December 2016, resulting in a record replenishment size of $75 billion to finance projects over the three-year period from July 1, 2017 to June 30, 2020.